CN1181975A - Injection for varicose vein - Google Patents
Injection for varicose vein Download PDFInfo
- Publication number
- CN1181975A CN1181975A CN 97118159 CN97118159A CN1181975A CN 1181975 A CN1181975 A CN 1181975A CN 97118159 CN97118159 CN 97118159 CN 97118159 A CN97118159 A CN 97118159A CN 1181975 A CN1181975 A CN 1181975A
- Authority
- CN
- China
- Prior art keywords
- injection
- vein
- varicose vein
- vitamin
- glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The injection is recompounded by using alpha-chymotrypsin as main component, glucose injection as solvent, and vitamin C and liquiritin as supplementary material. When injected into local vein with pathological change, it can cure varicose vein of the most patients in only once injection and has effective rate of 100%. Treatment with the said injection results no damage to skin and has low cost.
Description
The present invention relates to a kind of cirsoid local injection medication that is used for the treatment of.
Treatment varicosis adopts the operation method of exfoliation more at present, or laser radiation, and the former patient trauma greatly, easily causes hemorrhage, and non-critically ill patient is difficult for accepting.Laser therapy is effective in cure to slight patient, but to than heavy patient's weak curative effect.
Purpose of the present invention overcomes above-mentioned the deficiencies in the prior art exactly, and a kind of injection for varicose vein of simple and easy to do and determined curative effect is provided.
Through clinical observation and research for many years, we think that the cirsoid cause of disease has intravenous nutrition to lack, work is stood in work excessively, for a long time, have a cold humidity, and reason such as venous valve functional defect, be mainly sliding flesh of vein tube wall ring-shaped flat and interior elastic force film elasticity reduction, tube wall transition expansion, vein is intrinsic pressure in addition increase for a long time due to, only a few is due to the varicosis proximal occlusion.Thereby, it is main that the present invention adopts the medicine α pancreas Chymosin that can promote the vein tube wall to reply, strengthen tube wall elasticity and venous pressure holding capacity fast, with the glucose injection is solvent, auxiliary to have composite the forming of medicine vitamin C, glycyrrhizin of disease-resistant change vein degeneration necrosis effect, varicosis is carried out the local injection treatment, obtained better curative effect.
The present invention by the concrete prescription of an injection is:
α pancreas Chymosin 0.5mg
Vitamin C 0.75g
Glycyrrhizin 3ml
Adding 5% glucose again makes total amount to 20ml.
The present invention is a kind of compound preparation, acid-base value rationally, have no side effect.Inject the local patholoic change intravenous during use, and must not inject the normal vein blood vessel of whole body, ampoule is that 1-4 props up, i.e. 20-80ml.Show that through clinical application for many years the present invention is very simple and convenient, the Most patients injection once can be cured, and effective percentage is 100%, and cure rate is higher than 90%.Treatment back skin is excellent, and medical expense is cheap.Occurred local suppurative infection as the patient, should use antibiotic therapy earlier, made to infect and to adopt the present invention to control furuncle after controlled.
Claims (2)
1, a kind of injection for varicose vein, it is main it is characterized in that adopting α pancreas Chymosin, is solvent with the glucose injection, auxiliary with vitamin C, glycyrrhizin is composite forms.
2, injection for varicose vein as claimed in claim 1 is characterized in that by the prescription of an injection being:
α pancreas Chymosin 0.5mg
Vitamin C 0.75g
Glycyrrhizin 3ml
Adding 5% glucose again makes total amount to 20ml.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97118159A CN1063090C (en) | 1997-10-07 | 1997-10-07 | Injection for varicose vein |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97118159A CN1063090C (en) | 1997-10-07 | 1997-10-07 | Injection for varicose vein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1181975A true CN1181975A (en) | 1998-05-20 |
| CN1063090C CN1063090C (en) | 2001-03-14 |
Family
ID=5174682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97118159A Expired - Fee Related CN1063090C (en) | 1997-10-07 | 1997-10-07 | Injection for varicose vein |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1063090C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007065314A1 (en) * | 2005-12-08 | 2007-06-14 | Pficker Pharmaceuticals, Ltd. | Compound preparation for treating virus hepatopathy |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN88100253A (en) * | 1988-01-31 | 1988-11-02 | 梁声琼 | Synthetic technology for new medicine of anti-paralytic injection |
-
1997
- 1997-10-07 CN CN97118159A patent/CN1063090C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007065314A1 (en) * | 2005-12-08 | 2007-06-14 | Pficker Pharmaceuticals, Ltd. | Compound preparation for treating virus hepatopathy |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1063090C (en) | 2001-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Plikaitis et al. | Subatmospheric pressure wound therapy and the vacuum-assisted closure device: basic science and current clinical successes | |
| US5152757A (en) | System for diagnosis and treatment of wounds | |
| US20180263634A1 (en) | Percutaneous vascular injury treatment systems and methods | |
| Jackson et al. | A successful long-term method of fat grafting: Recontouring of a large subcutaneous postradiation thigh defect with autologous fat transplantation | |
| ROBERTS et al. | Upper extremity compartment syndromes following pit viper envenomation. | |
| JPH067441A (en) | Needle for infusion | |
| BRPI0414912A (en) | infuser system and method of administering medication to the patient | |
| CN1063090C (en) | Injection for varicose vein | |
| Holmes et al. | Rectus sheath hematoma as a cause of acute abdominal pain | |
| Panel | Consensus statement: benefits versus risks of medical therapy for acromegaly | |
| CN103007396B (en) | Injection device used under medical endoscope | |
| D’Asero et al. | Compartment syndrome of the hand with acute bullous eruption due to extravasation of computed tomography contrast material | |
| CN108309566A (en) | Rinse-system for negative-pressure sealed drainage | |
| CN204092743U (en) | Endocrinopathy injection positioner | |
| Sneyd et al. | Forearm compartment syndrome following intravenous infusion with a manual “bulb” pump | |
| 尹莹 | Blood-letting at a single point for treatment of acute diseases | |
| Vinod et al. | Acute compartment syndrome of hand resulting from radiographic contrast iohexol extravasation | |
| Girard et al. | Catheter fragmentation of pulmonary emboli | |
| Krivoshchekov et al. | The results of complex treatment of patients after metatarsal resection concerning complications of diabetic foot syndrome | |
| Fournier | Therapeutic megalipoextraction or megaliposculpture | |
| Ichiki et al. | Successful treatment of scleroderma-related cutaneous ulcer with suction blister grafting | |
| CN210698369U (en) | Novel urinary catheter for bladder irrigation | |
| CN208799626U (en) | A kind of fixed plate for infusion lengthened | |
| CN200970252Y (en) | Radial artery puncture point hemostat pressure device | |
| CN1233344C (en) | Externally applied piles-treating medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |